Hypotension and bradycardia associated with concomitant tizanidine and lisinopril therapy

Publow, Susan W.; Branam, Donald L.
October 2010
American Journal of Health-System Pharmacy;10/1/2010, Vol. 67 Issue 19/20, p1606
Academic Journal
Purpose. A case of severe bradycardia and hypotension associated with concomitant tizanidine and lisinopril therapy is reported. Summary. An 85-year-old man with a chief complaint of profound weakness was admitted to the hospital with a blood pressure reading of 60/32 mm Hg and a heart rate of 37 beats/min. His medical history included type 2 diabetes mellitus, congestive heart failure, gastroesophageal reflux disease, chronic obstructive pulmonary disease, osteoarthritis, restless leg syndrome, benign prostatic hyperplasia, generalized anxiety disorder with depression, and severe chronic back pain for which he was receiving treatment at a pain clinic. Two days before hospital admission, he had been seen at the pain clinic and started on tizanidine. Additional medications included acetaminophen, chlorpromazine, citalopram, finasteride, lidocaine patch, lisinopril, metformin, pramipexole, omeprazole, simvastatin, theophylline, diclofenac topical gel, hydrocodone-acetaminophen, and ondansetron. After taking three doses of the newly prescribed tizanidine, he developed severe hypotension and bradycardia. Notable laboratory test values included a serum creatinine concentration of 1.90 mg/dL, a blood urea nitrogen concentration of 21 mg/dL, a serum potassium concentration of 5.5 meq/L, and a serum sodium concentration of 128 meq/L. Upon admission, tizanidine, lisinopril, theophylline, omeprazole, and simvastatin were withheld, and i.v. fluids were administered. The patient's vital signs began to gradually improve. Within 24 hours, the patient's blood pressure and heart rate had improved, as had the previously abnormal laboratory test values. Tizanidine was discontinued, and all of his other preadmission medications were restarted at discharge. Conclusion. The addition of tizanidine in a patient receiving long-term treatment with lisinopril was associated with severe hypotension and bradycardia.


Related Articles

  • Impact of High-Dose ACE Inhibitors on CHF Treatment. Miller, Karl E. // American Family Physician;7/1/2001, Vol. 64 Issue 1, p164 

    Discusses research being done on the impact of high-dose versus standard-dose angiotensin-converting enzyme inhibitors on the mortality, morbidity and clinical status of patients with congestive heart failure. Reference to study by J.N. Nanas and colleagues, published in the December 2000 issue...

  • Enalapril Prevents Clinical Proteinuria in Diabetic Patients With Low Ejection Fraction. Capes, Sarah E.; Gerstein, Hertzel C.; Negassa, Abdissa; Yusuf, Salim // Diabetes Care;Mar2000, Vol. 23 Issue 3, p377 

    Presents a study which determined the prevalence of proteinuria at baseline and the effect of angiotensin converting enzyme inhibitors in preventing proteinuria in patients with congestive heart failure. Methodology; Results and discussion; Conclusions.

  • Metastatic Malignant Melanoma Presenting as Congestive Heart Failure: Diagnosis by Transoesophageal Echocardiography. Schneider, B; Zienkiewicz, T // European Journal of Echocardiography;2002, Vol. 3 Issue 2, p168 

    The article presents a case study of a 58-year-old man with congestive heart failure, which requires mechanical ventilation. He has a history of arterial hypertension that is controlled using diuretics, and angiotensin converting enzyme (ACE) inhibitors. He underwent left ventriculography and...

  • Heart failure patients may need higher doses of ACE inhibitors.  // Modern Medicine;Dec98, Vol. 66 Issue 12, p27 

    Presents an abstract of the study `Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure,' by A. B. Luzier, A. Forrest, M. Adelman, et al., which appeared in the `American Journal of Cardiology,' dated August 15, 1998.

  • Pharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort Study. Nelveg-Kristensen, Karl Emil; Busk Madsen, Majbritt; Torp-Pedersen, Christian; Køber, Lars; Egfjord, Martin; Berg Rasmussen, Henrik; Riis Hansen, Peter // PLoS ONE;12/3/2015, Vol. 10 Issue 12, p1 

    Background: Evidence for pharmacogenetic risk stratification of angiotensin-converting enzyme inhibitor (ACEI) treatment is limited. Therefore, in a cohort of ACEI-treated patients with congestive heart failure (CHF), we investigated the predictive value of two pharmacogenetic scores that...

  • Chronic obstructive pulmonary disease and its comorbidities. Rabinovich, Roberto A.; MacNee, William // British Journal of Hospital Medicine (17508460);Mar2011, Vol. 72 Issue 3, p137 

    The article reviews several studies on the prevalence of chronic obstructive pulmonary disease (COPD) and its complications due to systemic consequences and comorbidities. It highlights the pathogenic mechanisms due to cigarette smoking, and the clinical features of the systemic consequences of...

  • Omeprazole, Hypergastrinemia, and Gastric Carcinoid Tumors. Freston, James W. // Annals of Internal Medicine;8/1/94, Vol. 121 Issue 3, p232 

    Focuses on the long term management of reflux esophagitis. Reason for the reluctance to treat reflux esophagitis patients with omeprazole; Occurrence of gastric anterochromatlin-like cell carcinoid tumors in patients with massive hypergastrinemia; Development of Zollinger-Ellison sundrome in...

  • Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Castell, Donald O.; Kahrilas, Peter J.; Richter, Joel E.; Vakil, Nimish B.; Johnson, David A.; Zuckerman, Seth; Skammer, Wendy; Levine, Jeffrey G. // American Journal of Gastroenterology;Mar2002, Vol. 97 Issue 3, p575 

    OBJECTIVES:Esomeprazole, the S isomer of omeprazole, has been shown to have higher healing rates of erosive esophagitis than omeprazole. This study compared esomeprazole with lansoprazole for the healing of erosive esophagitis and resolution of heartburn.METHODS:This United States multicenter,...

  • Is omeprazole helpful in the management of children with reflux oesophagitis? Varughese, Lizy A.; Mazur, Lynnette J. // Archives of Disease in Childhood;Jul2002, Vol. 87 Issue 1, p78 

    Investigates the effectiveness of omeprazole in the management of children with reflux esophagitis. Five studies addressing clinical outcomes revealing improvement in the patients' symptoms; Relapse rates.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics